Article
Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study.
European journal of clinical pharmacology - 1 Dec 2005
Nieminen Tuomo, Uusitalo Hannu, Mäenpää Jukka, Turjanmaa Väinö, Rane Anders, Lundgren Stefan, Ropo Auli, Rontu Riikka, Lehtimäki Terho, Kähönen Mika
Abstract excerpt
OBJECTIVE: To test the hypotheses that (1) CYP2D6 genotype is associated with pharmacokinetics of ophthalmic timolol and (2) variation in genotypes of ADRB1 (beta(1)-adrenoceptor) and GNAS1 (alpha-subunit of G-protein) modulate heart rate (HR), and systolic (SAP) and diastolic (DAP) arterial pressure responses to timolol. METHODS: Nineteen glaucoma patients and eighteen healthy volunteers were treated with 0.5%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
